3646 results for «538»
3646 results
Closing remarks - PCR Innovators Day 2019
20 May 2019 – From PCR Innovators Day 2019
Consult this session to discover the closing remarks on PCR Innovators Day 2019, regarding the presentations of innovative technologies: Cavis Technologies' WireCath, CorFlow Therapeutics, Procerion and GENOSS.
EAPCI General Assembly
22 May 2019 – From EuroPCR 2019
Consult this session to discover the EAPCI General Assembly's slides, presented during EuroPCR 2019. Learn more about the different committees and the grants programme.
TAVI for aortic valve-in-valve - LIVE Case
22 May 2019 – From EuroPCR 2019
Consult this session to discover an exciting case, live transmitted during EuroPCR 2019: it will take you to a whole new territory of TAVI, focusing on the generation of bioprosthetic heart valves issues and the transcatheter solutions which are emerging as an optimal approach to this...
Treatment of bending zones in femoral and popliteal arteries - LIVE Case
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about the different characteristics of devices and treatment strategies including: directional atherectomy + drug-coated balloon, calcified plaque softening with lithoplasty, new stents conforming to anatomy, and more!
LIVE demonstration from Clinique Pasteur - Toulouse, France
The JenaValve Trilogy™ heart valve system in high surgical risk patients with symptomatic, severe aortic regurgitation: The ALIGN AR Trial
25 Oct 2023
Nicola Ryan provides her take on the ALIGN AR trial which was presented by Vinod H. Thourani at TCT Congress 2023. The Align AR trial is a prospective single-arm investigation device exemption study assessing the safety and efficacy of the Trilogy transcatheter heart valve system in patients with...
Author
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)